Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis
Author(s) -
Matteo Anselmino,
Mario Matta,
Fabrizio D’Ascenzo,
Carlo Pappone,
Vincenzo Santinelli,
T. Jared Bunch,
Thomas Neumann,
Richard J. Schilling,
Ross J. Hunter,
Georg Noelker,
Martin Fiala,
Antonio Frontera,
Glyn Thomas,
Demosthenes G. Katritsis,
Pierre Jaı̈s,
Rukshen Weerasooriya,
Jonathan M. Kalman,
Fiorenzo Gaïta
Publication year - 2015
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/euv214
Subject(s) - medicine , atrial fibrillation , catheter ablation , meta analysis , cardiology , diabetes mellitus , catheter , surgery , endocrinology
Diabetes mellitus (DM) and atrial fibrillation (AF) share pathophysiological links, as supported by the high prevalence of AF within DM patients. Catheter ablation of AF (AFCA) is an established therapeutic option for rhythm control in drug resistant symptomatic patients. Its efficacy and safety among patients with DM is based on small populations, and long-term outcome is unknown. The present systematic review and meta-analysis aims to assess safety and long-term outcome of AFCA in DM patients, focusing on predictors of recurrence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom